Compare PL & EXEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PL | EXEL |
|---|---|---|
| Founded | 2010 | 1994 |
| Country | United States | United States |
| Employees | 970 | N/A |
| Industry | Aerospace | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.9B | 11.4B |
| IPO Year | N/A | 2000 |
| Metric | PL | EXEL |
|---|---|---|
| Price | $35.26 | $44.36 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 13 | 21 |
| Target Price | $24.34 | ★ $46.45 |
| AVG Volume (30 Days) | ★ 15.7M | 2.0M |
| Earning Date | 03-19-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 57.95 |
| EPS | N/A | ★ 2.78 |
| Revenue | N/A | ★ $452,477,000.00 |
| Revenue This Year | $41.85 | $13.66 |
| Revenue Next Year | $29.44 | $13.39 |
| P/E Ratio | ★ N/A | $16.33 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.92 | $33.76 |
| 52 Week High | $38.21 | $48.74 |
| Indicator | PL | EXEL |
|---|---|---|
| Relative Strength Index (RSI) | 59.73 | 59.36 |
| Support Level | $5.84 | $40.53 |
| Resistance Level | $37.05 | $45.88 |
| Average True Range (ATR) | 3.67 | 1.04 |
| MACD | 0.26 | 0.34 |
| Stochastic Oscillator | 72.16 | 76.11 |
Planet Labs PBC is an Earth-imaging company. It uses space to help life on Earth by imaging the world every day and making change visible, accessible, and actionable. Its platform includes imagery, insights, and machine learning that empower companies, governments, and communities around the world to make timely decisions about the evolving world. Its solutions are Broad Area Management. Its products are Planet Monitoring, Planet Tasking, Planet Analytic Feeds, Planetary Variables, Planet Basemaps, Planet Insights, and Platform Pricing. The group provides solutions to the Agriculture Science Program, Energy & Infrastructure, Forestry & Land Use, Mapping, Sustainability, Maritime, Civil Government, U.S. State and Local, Europe, Planet Federal, Defense & Intelligence, and Armed Services.
Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.